NABP Issues Policy Statement Supporting the Pharmacist’s Role in Increasing Access to Opioid Overdose Reversal Drug
October 20, 2014 As the opioid overdose epidemic continues to take hundreds of lives each week, the National Association of Boards of Pharmacy® (NABP®) has issued a policy statement promoting an active role for pharmacists in expanding access to the opioid overdose reversal drug, naloxone. Nearly 17,000 people died from an overdose involving an opioid analgesic […]
Read More ›NCPO Statement on Combatting the Opioid Crisis
January 31, 2018 The National Conference of Pharmaceutical Organizations (NCPO) is a coalition of organizations and associations that represents the discovery, manufacture, and distribution of medications and practitioners that provide effective patient care. Collectively, our organizations represent over 300,000 individual pharmacy practitioners and pharmaceutical scientists, companies engaged in diverse aspects of healthcare delivery, and the […]
Read More ›